Sign In
Buy ILMN
$205.10
+0.0100 (+0.0049%)
At Close: Jul 31, 2026
Illumina, Inc. $ILMN Position Boosted by Citigroup Inc.
04:23am, Saturday, 28'th Feb 2026
Citigroup Inc. raised its holdings in shares of Illumina, Inc. (NASDAQ: ILMN) by 8.2% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission
Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida
09:15am, Friday, 27'th Feb 2026
Increased adoption of clinical whole-genome sequencing is advancing diagnostics for rare diseases, which affect 15 million American children SAN DIEGO, Feb. 27, 2026 /PRNewswire/ -- Illumina, Inc. (NA
TEM vs. ILMN: Which MedTech Stock Offers Greater Upside?
11:51am, Thursday, 26'th Feb 2026
In 2026, MedTech players' success will hinge on their ability to balance near-term pressure with long-term transformation. Per a report by ZS, these players must address immediate operational, financi
Takara Bio USA, Inc. Collaborates with Illumina on Spatial Transcriptomics Workflow, Details Presented at AGBT 2026
08:00am, Thursday, 26'th Feb 2026
SAN JOSE, Calif.--(BUSINESS WIRE)-- #NGS--Takara Bio USA collaborates with Illumina on a single-cell-resolution spatial mapping workflow, presented at AGBT 2026.
Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics
09:15am, Wednesday, 25'th Feb 2026
At AGBT, researchers reveal new findings from studies leveraging Illumina's multiomics solutions SAN DIEGO, Feb. 25, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced new customer bre
Illumina launches TruPath Genome, setting a new standard in genomic insight
12:15pm, Tuesday, 24'th Feb 2026
TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow Data presented at AGBT demonstrates TruPath Genome's accuracy in detecting rare genetic disease Broad Clin
Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility
09:15am, Monday, 23'rd Feb 2026
40% increase in output to 35 billion reads, up to Q70 quality scores, improved turnaround time, and staggered starts are among the updates to be rolled out on all NovaS eq X systems , advancing precis
Why Illumina (ILMN) is a Top Value Stock for the Long-Term
10:41am, Wednesday, 18'th Feb 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Short Interest in Illumina, Inc. (NASDAQ:ILMN) Expands By 28.6%
04:36am, Wednesday, 18'th Feb 2026
Illumina, Inc. (NASDAQ: ILMN - Get Free Report) saw a significant increase in short interest during the month of January. As of January 30th, there was short interest totaling 8,300,465 shares, an inc
Eagle Health Investments LP Sells 21,100 Shares of Illumina, Inc. $ILMN
04:03am, Wednesday, 18'th Feb 2026
Eagle Health Investments LP lowered its stake in shares of Illumina, Inc. (NASDAQ: ILMN) by 6.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Comm
Illumina To Webcast Upcoming Investor Conference
03:10pm, Tuesday, 17'th Feb 2026
SAN DIEGO, Feb. 17, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that members of its management team will participate at the following investor conference: Upcoming Investor Conf
Caprock Group LLC Makes New $1.48 Million Investment in Illumina, Inc. $ILMN
04:10am, Sunday, 15'th Feb 2026
Caprock Group LLC purchased a new position in Illumina, Inc. (NASDAQ: ILMN) during the undefined quarter, according to its most recent 13F filing with the SEC. The firm purchased 14,794 shares of the
Illumina (ILMN) is a Top-Ranked Growth Stock: Should You Buy?
10:46am, Thursday, 12'th Feb 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Illumina Q4 Earnings & Revenues Top Estimates, Stock Dips
09:25am, Thursday, 12'th Feb 2026
ILMN tops Q4 EPS and revenue estimates, posts 42% profit jump, but shares slide 10% on margin concerns despite 2026 growth outlook.
Unlocking Illumina (ILMN) International Revenues: Trends, Surprises, and Prospects
10:17am, Monday, 09'th Feb 2026
Evaluate Illumina's (ILMN) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
